OBJECTIVE	The primary objective of this study is to determine whether daily exit-site application of standardized antibacterial honey ( Medihoney Antibacterial Wound Gel ; Comvita , Te Puke , New Zealand ) results in a reduced risk of catheter-associated infections in peritoneal dialysis ( PD ) patients compared with standard topical mupirocin prophylaxis of nasal staphylococcal carriers .\